Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer.
par Lan, Qiang;Peyvandi, Sanam;Duffey, Nathalie;Huang, Yu-Ting;Barras, David;Held, Werner;Richard, François;Delorenzi, Mauro;Sotiriou, Christos ;Desmedt, Christine ;Lorusso, Girieca;Rüegg, Curzio
Référence Oncogene
Publication Publié, 2018-12-01
Référence Oncogene
Publication Publié, 2018-12-01
Article révisé par les pairs
Titre: |
|
Auteur: | Lan, Qiang; Peyvandi, Sanam; Duffey, Nathalie; Huang, Yu-Ting; Barras, David; Held, Werner; Richard, François; Delorenzi, Mauro; Sotiriou, Christos; Desmedt, Christine; Lorusso, Girieca; Rüegg, Curzio |
Informations sur la publication: | Oncogene |
Statut de publication: | Publié, 2018-12-01 |
Sujet CREF: | Cancérologie |
Sciences bio-médicales et agricoles | |
Médecine pathologie humaine | |
MeSH keywords: | Animals |
Antineoplastic Combined Chemotherapy Protocols -- pharmacology | |
Biomarkers, Tumor -- metabolism | |
Breast Neoplasms -- drug therapy -- metabolism | |
Cell Line, Tumor | |
Chemotherapy, Adjuvant -- methods | |
Doxorubicin -- pharmacology | |
Epirubicin -- pharmacology | |
Female | |
Humans | |
Interferon Regulatory Factor-7 -- metabolism | |
Interferon Type I -- metabolism | |
Interferon-beta -- metabolism | |
Methotrexate -- pharmacology | |
Mice | |
Mice, Inbred BALB C | |
Mice, Inbred NOD | |
Mice, Nude | |
Mice, SCID | |
Neoadjuvant Therapy -- methods | |
Neoplasm Recurrence, Local -- metabolism | |
Receptor, ErbB-2 -- metabolism | |
Note générale: | SCOPUS: ar.j |
Langue: | Anglais |
Identificateurs: | urn:issn:0950-9232 |
info:doi/10.1038/s41388-018-0624-2 | |
info:pii/10.1038/s41388-018-0624-2 | |
info:scp/85058436373 | |
info:pmid/30546090 | |
PMC6477891 |